Search Results - "Hughes, G RV"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome by Ruiz-Irastorza, G, Khamashta, M A, Hughes, G RV

    Published in Lupus (01-01-2001)
    “…Antiaggregant and anticoagulant drugs are essential in the management of the manifestations due to antiphospholipid syndrome (APS) in patients with primary…”
    Get full text
    Book Review Journal Article
  2. 2

    Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients by Shah, N M, Khamashta, M A, Atsumi, T, Hughes, G R

    Published in Lupus (1998)
    “…We report a 10-year follow-up on 52 patients with raised levels of anticardiolipin antibodies (aCL) who were first seen at our tertiary referral centre in…”
    Get more information
    Journal Article
  3. 3

    Theory, targets and therapy in systemic lupus erythematosus by Vasoo, S, Hughes, G RV

    Published in Lupus (01-01-2005)
    “…The treatment of systemic lupus erythematosus (SLE) has been refined over the years, with the recognition that a fine balance lies between aggressive and…”
    Get full text
    Journal Article
  4. 4

    Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus by Salido, M, Macarron, P, Hernández-García, C, D’Cruz, D P, Khamashta, M A, Hughes, G RV

    Published in Lupus (01-01-2003)
    “…Cyclophosphamide(CY) is an alkylating agent used to treat a variety of autoimmune disorders.Water intoxication is a well-known complication of high-dose…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    MALToma and lupus by Oliveri, C, Hughes, G RV, D’Cruz, D P

    Published in Lupus (01-01-2005)
    “…We present two patients with low-grade non-Hodgkin MALT lymphoma (mucosa-associated lymphoid tissue) occurring years before clinical evidence of autoimmune…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Lupus pregnancy: is heparin a risk factor for osteoporosis? by Ruiz-Irastorza, G, Khamashta, M A, Nelson-Piercy, C, Hughes, G RV

    Published in Lupus (01-01-2001)
    “…Regulation of calcium homeostasis during pregnancy is complex. Clinically significant bone mass loss is infrequent; however a subset of women may develop…”
    Get full text
    Book Review Journal Article
  10. 10

    Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis by Romero, F I, Khamashta, M A, Hughes, G RV

    Published in Lupus (01-01-2000)
    “…Lipoprotein(a) (Lp(a)) is considered a vascular pathogen of outstanding importance. High plasma levels of this lipoprotein are associated with premature…”
    Get full text
    Book Review Journal Article
  11. 11

    Endocarditis and ulnar artery aneurysm as presenting features of antiphospholipid syndrome and polyarteritis nodosa by Egan, A C, Caleyachetty, R, Sabharwal, T, Harper, B, Tomlinson, M, Kirkham, B, Hughes, G RV, D’Cruz, D

    Published in Lupus (01-01-2005)
    “…Antiphospholipid syndrome in association with vasculitis is highlighted in this report. The combination of thrombotic and inflammatory processes resulted in…”
    Get full text
    Journal Article
  12. 12

    Heparin and osteoporosis during pregnancy: 2002 update by Ruiz-Irastorza, G, Khamashta, M A, Hughes, G RV

    Published in Lupus (01-01-2002)
    “…Althoughsignificant bone mass loss is rare duringpregnancy,some situationsmay increasethe risk of symptomaticosteoporosis.Heparin may be necessaryfor a number…”
    Get full text
    Journal Article
  13. 13

    Update on therapy — thalidomide in the treatment of lupus by Karim, M Y, Ruiz-Irastorza, G, Khamashta, M A, Hughes, G RV

    Published in Lupus (01-01-2001)
    “…Thalidomide has been shown to be an effective treatment for cutaneous forms of lupus erythematous refractory to other therapies. Thalidomide has very serious…”
    Get full text
    Book Review Journal Article
  14. 14
  15. 15

    Immunology, lupus and atheroma by Hughes, G RV

    Published in Lupus (01-01-2000)
    Get full text
    Journal Article
  16. 16

    Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome by Matsuura, E, Kobayashi, K, Koike, T, Shoenfeld, Y, Khamashta, M A, Hughes, G RV

    Published in Lupus (01-01-2003)
    “…β2-Glycoprotein I (β2-GPI) is a major antigen for anticardiolipin antibodies (aCL, Abs) present in patients with antiphospholipidsyndrome (APS). We recently…”
    Get full text
    Journal Article
  17. 17

    Polymorphic light eruption and the HLA DRB10301 extended haplotype are independent risk factors for cutaneous lupus erythematosus by Millard, T P, Kondeatis, E, Vaughan, R W, Lewis, C M, Khamashta, M A, Hughes, G RV, Hawk, J LM, Mcgregor, J M

    Published in Lupus (01-01-2001)
    “…Recent evidence suggests that polymorphic light eruption (PLE) is an inherited photosensitivity disorder which may predispose to cutaneous lupus erythematosus…”
    Get full text
    Journal Article
  18. 18

    European Working Party on Systemic Lupus Erythematosus: a 10 year report by Cervera, R, Khamashta, M A, Font, J, Hughes, G RV

    Published in Lupus (01-01-2001)
    “…The 'European Working Party on Systemic Lupus Erythematosus (SLE)' was created in 1990 in order to promote research in Europe on the different problems related…”
    Get full text
    Journal Article